These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38953734)

  • 1. Inequalities in Access to Diabetes Technologies in Children with Type 1 Diabetes: A Multicenter, Cross-sectional Study from Türkiye.
    Karakus KE; Sakarya S; Yıldırım R; Özalkak Ş; Özbek MN; Yıldırım N; Delibağ G; Eklioğlu BS; Haliloğlu B; Aydın M; Kırmızıbekmez H; Gökçe T; Can E; Eviz E; Yeşiltepe-Mutlu G; Hatun Ş
    J Clin Res Pediatr Endocrinol; 2024 Jul; ():. PubMed ID: 38953734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycemic Control in Relation to Technology Use in a Single-Center Cohort of Children with Type 1 Diabetes.
    Sawyer A; Sobczak M; Forlenza GP; Alonso GT
    Diabetes Technol Ther; 2022 Jun; 24(6):409-415. PubMed ID: 35099306
    [No Abstract]   [Full Text] [Related]  

  • 3. Observed Characteristics Associated with Diabetes Device Use Among Teens with Type 1 Diabetes.
    Chen CW; Tinsley LJ; Volkening LK; Anderson BJ; Laffel LM
    J Diabetes Sci Technol; 2023 Jan; 17(1):186-194. PubMed ID: 34652236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin Pump Use in Young Children with Type 1 Diabetes: Sociodemographic Factors and Parent-Reported Barriers.
    Commissariat PV; Boyle CT; Miller KM; Mantravadi MG; DeSalvo DJ; Tamborlane WV; Van Name MA; Anderson BJ; DiMeglio LA; Laffel LM
    Diabetes Technol Ther; 2017 Jun; 19(6):363-369. PubMed ID: 28581817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous glucose monitoring systems for type 1 diabetes mellitus.
    Langendam M; Luijf YM; Hooft L; Devries JH; Mudde AH; Scholten RJ
    Cochrane Database Syst Rev; 2012 Jan; 1(1):CD008101. PubMed ID: 22258980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Current Diabetes Technology Improve Metabolic Control? A Cross-Sectional Study on the Use of Insulin Pumps and Continuous Glucose Monitoring Devices in a Nationwide Pediatric Population.
    Bratke H; Margeirsdottir HD; Assmus J; Njølstad PR; Skrivarhaug T
    Diabetes Ther; 2021 Sep; 12(9):2571-2583. PubMed ID: 34389930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Initiation of Diabetes Devices Relates to Improved Glycemic Control in Children with Recent-Onset Type 1 Diabetes Mellitus.
    Patton SR; Noser AE; Youngkin EM; Majidi S; Clements MA
    Diabetes Technol Ther; 2019 Jul; 21(7):379-384. PubMed ID: 31166808
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of Achieving Time in Range Clinical Targets With Treatment Modality Among Youths With Type 1 Diabetes.
    Dovc K; Lanzinger S; Cardona-Hernandez R; Tauschmann M; Marigliano M; Cherubini V; Preikša R; Schierloh U; Clapin H; AlJaser F; Pelicand J; Shukla R; Biester T
    JAMA Netw Open; 2023 Feb; 6(2):e230077. PubMed ID: 36808243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fear of hypoglycemia in children with type 1 diabetes and their parents: Effect of pump therapy and continuous glucose monitoring with option of low glucose suspend in the CGM TIME trial.
    Verbeeten KC; Perez Trejo ME; Tang K; Chan J; Courtney JM; Bradley BJ; McAssey K; Clarson C; Kirsch S; Curtis JR; Mahmud FH; Richardson C; Cooper T; Lawson ML;
    Pediatr Diabetes; 2021 Mar; 22(2):288-293. PubMed ID: 33179818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
    Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
    Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Diabetes Technologies and Retinopathy in Adults With Type 1 Diabetes.
    Liu TYA; Shpigel J; Khan F; Smith K; Prichett L; Channa R; Kanbour S; Jones M; Abusamaan MS; Sidhaye A; Mathioudakis N; Wolf RM
    JAMA Netw Open; 2024 Mar; 7(3):e240728. PubMed ID: 38446483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Socioeconomic status and diabetes technology use in youth with type 1 diabetes: a comparison of two funding models.
    Lomax KE; Taplin CE; Abraham MB; Smith GJ; Haynes A; Zomer E; Ellis KL; Clapin H; Zoungas S; Jenkins AJ; Harrington J; de Bock MI; Jones TW; Davis EA
    Front Endocrinol (Lausanne); 2023; 14():1178958. PubMed ID: 37670884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motivational Stage at Continuous Glucose Monitoring (CGM) Initiation in Pediatric Type 1 Diabetes Is Associated With Current Glycemic Control but Does Not Predict Future CGM Adherence or Glycemic Control.
    Verbeeten KC; Chan J; Sourial N; Courtney JM; Bradley BJ; McAssey K; Clarson C; Kirsch S; Curtis JR; Mahmud FH; Cooper T; Richardson C; Lawson ML; ;
    Can J Diabetes; 2021 Jul; 45(5):466-472.e4. PubMed ID: 34176610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inequity in access to continuous glucose monitoring and health outcomes in paediatric diabetes, a case for national continuous glucose monitoring funding: A cross-sectional population study of children with type 1 diabetes in New Zealand.
    Burnside MJ; Williman JA; Davies HM; Jefferies CA; Paul RG; Wheeler BJ; Wiltshire EJ; Anderson YC; de Bock MI
    Lancet Reg Health West Pac; 2023 Feb; 31():100644. PubMed ID: 36419466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediating Effects of Technology-Based Therapy on the Relationship Between Socioeconomic Status and Glycemic Management in Pediatric Type 1 Diabetes.
    Stanley JR; Clarke ABM; Shulman R; Mahmud FH
    Diabetes Technol Ther; 2023 Mar; 25(3):186-193. PubMed ID: 36409503
    [No Abstract]   [Full Text] [Related]  

  • 18. Outcomes in Pump- and CGM-Baseline Use Subgroups in the International Diabetes Closed-Loop Trial.
    Ekhlaspour L; Raghinaru D; Forlenza GP; Isganaitis E; Kudva YC; Lam DW; Levister C; O'Malley G; Church MM; Lum JW; Buckingham B; Brown SA
    J Diabetes Sci Technol; 2023 Jul; 17(4):935-942. PubMed ID: 35473359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fully Closed-Loop Glucose Control Compared With Insulin Pump Therapy With Continuous Glucose Monitoring in Adults With Type 1 Diabetes and Suboptimal Glycemic Control: A Single-Center, Randomized, Crossover Study.
    Boughton CK; Hartnell S; Lakshman R; Nwokolo M; Wilinska ME; Ware J; Allen JM; Evans ML; Hovorka R
    Diabetes Care; 2023 Nov; 46(11):1916-1922. PubMed ID: 37616583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socioeconomic Disparities in Glycemic Management in Children and Youth With Type 1 Diabetes: A Retrospective Cohort Study.
    Simba S; Von Oettingen JE; Rahme E; Ladd JM; Nakhla M; Li P
    Can J Diabetes; 2023 Dec; 47(8):658-664.e2. PubMed ID: 37481125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.